ENODUB Trademark

Trademark Overview

On Monday, January 6, 2014, a trademark application was filed for ENODUB with the United States Patent and Trademark Office. The USPTO has given the ENODUB trademark a serial number of 86157954. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 19, 2018. This trademark is owned by Bristol-Myers Squibb Company. The ENODUB trademark is filed in the Pharmaceutical Products category with the following description:

Prescription-only pharmaceuticals for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, excluding pharmaceuticals to treat gastrointestinal conditions and disorders; Prescription-only pharmaceuticals for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies, excluding pharmaceuticals to treat gastrointestinal conditions and disorders
enodub

General Information

Serial Number86157954
Word MarkENODUB
Filing DateMonday, January 6, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 19, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 16, 2014

Trademark Statements

Goods and ServicesPrescription-only pharmaceuticals for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, excluding pharmaceuticals to treat gastrointestinal conditions and disorders; Prescription-only pharmaceuticals for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies, excluding pharmaceuticals to treat gastrointestinal conditions and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 16, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10154
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Monday, March 19, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, March 19, 2018ABANDONMENT - NO USE STATEMENT FILED
Thursday, August 17, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 16, 2017EXTENSION 5 GRANTED
Thursday, August 10, 2017EXTENSION 5 FILED
Thursday, August 10, 2017TEAS EXTENSION RECEIVED
Tuesday, February 14, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 10, 2017EXTENSION 4 GRANTED
Friday, February 10, 2017EXTENSION 4 FILED
Friday, February 10, 2017TEAS EXTENSION RECEIVED
Thursday, August 18, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 17, 2016EXTENSION 3 GRANTED
Wednesday, August 10, 2016EXTENSION 3 FILED
Wednesday, August 10, 2016TEAS EXTENSION RECEIVED
Saturday, March 12, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 11, 2016EXTENSION 2 GRANTED
Monday, February 8, 2016EXTENSION 2 FILED
Thursday, March 10, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, February 8, 2016TEAS EXTENSION RECEIVED
Wednesday, August 12, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 10, 2015EXTENSION 1 GRANTED
Monday, August 10, 2015EXTENSION 1 FILED
Monday, August 10, 2015TEAS EXTENSION RECEIVED
Tuesday, February 10, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 16, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 16, 2014PUBLISHED FOR OPPOSITION
Wednesday, November 26, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, November 8, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, November 6, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 6, 2014EXAMINER'S AMENDMENT ENTERED
Thursday, November 6, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, November 6, 2014EXAMINERS AMENDMENT E-MAILED
Thursday, November 6, 2014EXAMINERS AMENDMENT -WRITTEN
Wednesday, November 5, 2014PREVIOUS ALLOWANCE COUNT WITHDRAWN
Wednesday, November 5, 2014WITHDRAWN FROM PUB - EXAMINING ATTORNEY REQUEST
Friday, October 31, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, October 30, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 30, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 14, 2014ASSIGNED TO LIE
Friday, October 10, 2014TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, October 9, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 8, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 7, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 7, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 1, 2014ASSIGNED TO EXAMINER
Monday, April 7, 2014NOTIFICATION OF PRIORITY ACTION E-MAILED
Monday, April 7, 2014PRIORITY ACTION E-MAILED
Monday, April 7, 2014PRIORITY ACTION WRITTEN
Wednesday, April 2, 2014ASSIGNED TO EXAMINER
Thursday, January 16, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, January 9, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

enodub diseases pharmaceuticals disorders excluding conditions anti treat prescription human only